MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA – Get Free Report)’s stock price dropped 3.4% during trading on Thursday . The company traded as low as $2.36 and last traded at $2.57. Approximately 120,695 shares changed hands during trading, a decline of 59% from the average daily volume of 292,118 shares. The stock had previously closed at $2.66.
MAIA Biotechnology Stock Performance
The stock has a market cap of $61.45 million, a price-to-earnings ratio of -1.58 and a beta of 0.31.
MAIA Biotechnology (NYSEAMERICAN:MAIA – Get Free Report) last issued its earnings results on Friday, August 9th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.16. On average, equities analysts anticipate that MAIA Biotechnology, Inc. will post -1.25 earnings per share for the current fiscal year.
Institutional Trading of MAIA Biotechnology
About MAIA Biotechnology
MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.
Featured Stories
- Five stocks we like better than MAIA Biotechnology
- Manufacturing Stocks Investing
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Differences Between Momentum Investing and Long Term Investing
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Invest in Insurance Companies: A GuideĀ
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for MAIA Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAIA Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.